138 related articles for article (PubMed ID: 17848739)
1. Serum IL-8 and IL-12 levels in breast cancer.
Derin D; Soydinc HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Med Oncol; 2007; 24(2):163-8. PubMed ID: 17848739
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients.
Ahmed OI; Adel AM; Diab DR; Gobran NS
Egypt J Immunol; 2006; 13(2):61-8. PubMed ID: 18689272
[TBL] [Abstract][Full Text] [Related]
3. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
[TBL] [Abstract][Full Text] [Related]
4. Serum and urine survivin levels in breast cancer.
Guney N; Soydine HO; Derin D; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Med Oncol; 2006; 23(3):335-9. PubMed ID: 17018890
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
6. Serum IL-6 and IL-12 levels in breast cancer patients.
Hussein MZ; Al Fikky A; Abdel Bar I; Attia O
Egypt J Immunol; 2004; 11(2):165-70. PubMed ID: 16734129
[TBL] [Abstract][Full Text] [Related]
7. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
Zhang GJ; Adachi I
Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
[TBL] [Abstract][Full Text] [Related]
9. Correlations of MRP1 gene with serum TGF-β1 and IL-8 in breast cancer patients during chemotherapy.
Zhuang X; Wang J
J BUON; 2018; 23(5):1302-1308. PubMed ID: 30570851
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
Tas F; Bilgin E; Karabulut S; Duranyildiz D
Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta glucan on white blood cell counts and serum levels of IL-4 and IL-12 in women with breast cancer undergoing chemotherapy: a randomized double-blind placebo-controlled clinical trial.
Ostadrahimi A; Ziaei JE; Esfahani A; Jafarabadi MA; Movassaghpourakbari A; Farrin N
Asian Pac J Cancer Prev; 2014; 15(14):5733-9. PubMed ID: 25081694
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients.
Bordbar E; Malekzadeh M; Ardekani MT; Doroudchi M; Ghaderi A
Asian Pac J Cancer Prev; 2012; 13(10):5307-12. PubMed ID: 23244154
[TBL] [Abstract][Full Text] [Related]
15. Effect of standard anthracycline based neoadjuvant chemotherapy on circulating levels of serum IL-6 in patients of locally advanced carcinoma breast - a prospective study.
Gupta N; Goswami B; Mittal P
Int J Surg; 2012; 10(10):638-40. PubMed ID: 23164989
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
[TBL] [Abstract][Full Text] [Related]
17. [Value of interleukin-8 determination in diagnosis of benign and malignant breast tumor].
Zakrzewska I; Kozłowski L; Wojtukiewicz M
Pol Merkur Lekarski; 2002 Oct; 13(76):302-4. PubMed ID: 12557436
[TBL] [Abstract][Full Text] [Related]
18. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report.
Yokoe T; Iino Y; Morishita Y
Breast Cancer; 2000; 7(3):187-90. PubMed ID: 11029796
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.
Gangemi S; Minciullo P; Adamo B; Franchina T; Ricciardi GR; Ferraro M; Briguglio R; Toscano G; Saitta S; Adamo V
J Cell Biochem; 2012 Jun; 113(6):2122-5. PubMed ID: 22298331
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.
Pusztai L; Mendoza TR; Reuben JM; Martinez MM; Willey JS; Lara J; Syed A; Fritsche HA; Bruera E; Booser D; Valero V; Arun B; Ibrahim N; Rivera E; Royce M; Cleeland CS; Hortobagyi GN
Cytokine; 2004 Feb; 25(3):94-102. PubMed ID: 14698135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
